Institutional investors purchased a net $1.0 million shares of CCXI during the quarter ended September 2014. This may signal that the smart money is gaining interest in this company as the 63.75% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FIRST MANHATTAN CO. Bought 260.5 Thousand shares of ChemoCentryx Inc
MEDICAL STRATEGY GMBH Sold 12.3 Thousand shares of ChemoCentryx Inc